Veriheal

OCTOBER 13, 2023

Senator Jeff Irwin, the bill’s sponsor, argued that we must acknowledge the growing research on the potential of psychedelics to help with mental health conditions. Specifically, the Senator emphasized how these substances could help veterans experiencing conditions like PTSD and depression. Ketamine Therapy For All?

Therapy 98

Therapy Legalization Recreational Policy 98

Cannabis Law Report

OCTOBER 4, 2021

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

Veriheal

APRIL 3, 2024

Naropa University in Boulder, Colorado, has created an exciting new initiative for students: a minor in psychedelic studies, designed to train those who want to practice psychedelic-assisted therapy and other related careers. It’s tailored for students interested in exploring past and contemporary uses of psychedelics. in a statement.

Therapy 67

Therapy Education Programs Medicine 67

NORML

JUNE 14, 2019

Next week, the two key committees will hold hearings on various aspects of federal marijuana policy. Ultimately, this prohibition on access to resources hampers the potential to create a robust and competitive marketplace for consumers. Small Businesses in the Cannabis Industry. Presently, V.A.

Marijuana 278

Marijuana Access Programs Legislation 278

MMJ Recs

MAY 1, 2024

It’s a time for both individuals and organizations to engage in conversations, initiatives, and activities aimed at reducing stigma, increasing understanding, and fostering empathy surrounding mental health conditions. Medical marijuana, with its purported mood-regulating properties, emerges as a potential adjunctive therapy.

Marijuana 98

Marijuana Treatment Conditions Chronic Pain 98

Veriheal

MARCH 20, 2023

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

MMJ Recs

JANUARY 24, 2024

Today we’ll take a closer look at the Michigan Medical Marijuana Program, giving Michigan citizens all the info they need about accessing MMJ in the state. The state legalized medical marijuana in 2008, establishing a framework for patients to access cannabis for therapeutic purposes.

Programs 52

Programs Marijuana Access Chronic Pain 52

Cannabis Law Report

FEBRUARY 9, 2022

This is a breakthrough therapy and it shows promise, but the science is not there yet.”. A Maine therapist with two patients benefiting from psychedelic drug-assisted therapy to treat PTSD and depression also expressed disappointment. A 43-year-old Portland man said psilocybin therapy helped him forgive himself and others. “In

Therapy 52

Therapy Treatment Decriminalization Patients 52

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

Cannabis Law Report

JUNE 5, 2021

Among other questions, the poll asked: To what extent would you support or oppose the government relaxing restrictions on research into the medical use of magic mushroom-based treatments (psilocybin- assisted therapies) for mental health conditions if this didn’t affect how it was classified in criminal law (e.g. as a class A drug)?

Therapy 81

Therapy Policy Education Treatment 81

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Legalization and Regulation of Medical Marijuana The journey of legalizing and regulating medical marijuana in the US reflects a nuanced interplay of federal and state policies.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients.

Policy 161

Policy Patients Education Legislation 161

Veriheal

FEBRUARY 23, 2024

As such, we hope that in treating the wounds of war — both visible and invisible — that our servicemembers and veterans would have access to the widest array of possible treatments,” writes an excerpt from the veterans’ letter, via NBC News.

DEA 99

DEA Chronic Pain Treatment Therapy 99

MMJ Recs

MARCH 20, 2024

Through these specialized services, Maryland dispensaries play a crucial role in providing accessible and quality medical cannabis options to patients statewide. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

Veriheal

OCTOBER 20, 2021

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

PrestoDoctor

JANUARY 30, 2024

Cannabis-induced psychosis is a unique mental health condition that is triggered by the use of cannabis, a psychoactive plant. This condition is characterized by the manifestation of psychotic symptoms such as hallucinations, delusions, and disorganized thinking. A family history of psychosis also adds to the risk.

Research and Development 52

Research and Development Treatment Conditions Education 52

Cannabis Law Report

JUNE 24, 2022

Scutari’s proposed “Psilocybin Behavioral Health Access and Services Act” represents a bold development in the psychedelics reform movement that’s rapidly spread in state legislatures and through citizen-led initiatives throughout the country in recent years.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse. Legislation is pending, House Bill 350, to expand medical cannabis access.

Legislation 196

Legislation Decriminalization Hemp Patients 196

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Veriheal

OCTOBER 19, 2022

Warastuti, the mother of Pika Sasi Kirana, is actively lobbying for legal access and research into the plant alongside her daughter’s father, Sunarta. In 14-year-old Pika’s case, there were no obvious signs of a medical condition when she was first born. Mothers Push for Cannabis Access in Indonesia. Weighing 3.4

Legalization 104

Legalization Research and Development Chronic Pain Treatment 104

MMJ Recs

JANUARY 20, 2024

Maryland, a trailblazer in progressive healthcare policies, has been part of this trend. The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

Cannabis Law Report

JULY 29, 2021

ACT Medical is a community-based organization providing in-depth assessment, customized treatment and counselling to patients suffering from opioid use disorder, chronic pain, and mental health conditions. Recovery is the focus of ACT Medical’s policies and practices. About Levitee Labs . www.leviteelabs.com.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). About MAPS Public Benefit Corporation (MAPS PBC). Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Click here to email your lawmakers in support of banking access. John Fetterman, Lt. CA resident? CA resident? CO resident? Connecticut.

Legislation 162

Legislation Decriminalization Access Patients 162

Veriheal

NOVEMBER 11, 2023

Nonetheless, with the increasing legalization of medical cannabis, many veterans and interest groups have asked the government to change its policies. Although the VA cannot pay for medical cannabis prescriptions for veterans, they can confidentially discuss its use with their veteran patients if it’ll help their condition.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

NORML

MARCH 14, 2020

Veteran Access : HR 1647, the Veterans Equal Access Act, would allow V.A. Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Your Highness, Carly. Actions to Take.

Legislation 186

Legislation Access Patients THC 186

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.

Dispensary 52

Dispensary Patients Marijuana Education 52

NORML

JANUARY 18, 2019

At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. A medical cannabis access bill was signed into law in the U.S. If passed, this bill provides registered patients with regulated access to medical cannabis via licensed providers. NE resident?

Legislation 161

Legislation Decriminalization Access Therapy 161

NORML

MARCH 7, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The measure would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder as well as opioid use disorder.

Legislation 231

Legislation Decriminalization Patients THC 231

NORML

FEBRUARY 8, 2019

Senator Ron Wyden introduced legislation in the Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation 174

Legislation Decriminalization Patients Access 174

Cannabis Law Report

DECEMBER 1, 2021

As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Emma teaches classes on integrating kink-based consent practices into psychedelic-assisted therapy.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

MAY 25, 2022

May 25, 2022 – SACRAMENTO – Senator Scott Wiener (D-San Francisco)’s Senate Bill 1186 , which restores voter-created access to medicinal cannabis across the state by requiring cities to provide patients access to purchase medicinal cannabis by delivery, passed the Senate with a unanimous bipartisan vote. 20210SB1186_96.

Medicine 52

Medicine Legislation Chronic Pain Access 52

Canna Law Blog

NOVEMBER 6, 2021

But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

The Cannigma

JUNE 1, 2021

Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Some 170 hospitals will participate in the two-year experiment. Who can get medical cannabis in France?

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

JUNE 3, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59